A COVID vaccine developed by Valneva has been granted regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA).
It is the sixth coronavirus vaccine to be granted an MHRA authorisation.
The UK’s independent medicines regulator is the first in the world to approve the Valneva product, MHRA said in a statement.
MHRA chief executive Dr June Raine said: “Our approval of the COVID-19 vaccine made by Valneva today follows a rigorous review of the safety, quality and effectiveness of this vaccine, and expert advice from the government’s independent scientific advisory body, the Commission on Human Medicines.”
